Antiphospholipid Syndrome: Not All Antibodies Are Created Equal
Nicola Pozzi, Associate Professor of Thrombosis and Hemostasis and Autoimmunity at Saint Louis University School of Medicine, shared a post on LinkedIn:
”Antiphospholipid Syndrome (APS) isn’t a one-size-fits-all disease—and neither are antiphospholipid antibodies.
In our latest work, led by Suresh Kumar, we advance understanding of the molecular complexity behind pathogenic antibodies targeting β2GPI and, in doing so, we introduce new concepts and tools that may help achieve more personalized diagnostic strategies and accelerate the development of neutralization approaches.
Our goal of building an Antiphospholipid Antibody Atlas to fight APS continues… Just keep watching APS…Just keep watching…”
For more information
Find More Posts on Hemostasis Today.
-
Mar 3, 2026, 17:12Matteo Foschi: Cancer Worsens Prognosis after Breakthrough Ischemic Stroke Despite Oral Anticoagulation
-
Mar 3, 2026, 17:04Shiny K Kajal: Therapeutic Apheresis Is Redefining the Clinical Scope of Transfusion Medicine
-
Mar 3, 2026, 16:58Non-Carrier Mothers of Inv22 Hemophilia A Patients Frequently Harbor Additional F8 Gene Rearrangements – JTH
-
Mar 3, 2026, 16:53Valentina Rossi: Addressing Inflammation and Immune Mechanisms in Cardiomyopathy Management
-
Mar 3, 2026, 16:45Emmanuel J Favaloro: New Publication on Artificial Intelligence in Thrombosis and Hemostasis in CCLM
-
Mar 3, 2026, 16:32Scott E. Smith: Why Hematology Research Is the True Leader of all Medical Disciplines
-
Mar 3, 2026, 16:21Tareq Abadl: Why HIV Antibodies Stay Positive Even When Viral Load Is Zero?
-
Mar 3, 2026, 16:12Mark Crowther Congratulates Mary Cushman on Her Appointment as ISTH President
-
Mar 3, 2026, 15:42Cheng-Hock Toh։ The Unrecognised Central Role of Hematology in Healthcare Design